HomeEnvisagenics

Envisagenics

Envisagenics Announces Research Program with the Lung Cancer Initiative at Johnson & Johnson

Through this initiative, Envisagenics will build predictive models for lung cancer progression and risk. The Envisagenics team will leverage its expertise in splicing and RNA-sequencing to analyze LCI's data using Envisagenics' SpliceCore® software platform.